POSC280 Economic Evaluation of Nivolumab Plus Ipilimumab in Advanced Renal-Cell Carcinoma in Japan
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.917
https://www.valueinhealthjournal.com/article/S1098-3015(21)02712-1/fulltext
Title :
POSC280 Economic Evaluation of Nivolumab Plus Ipilimumab in Advanced Renal-Cell Carcinoma in Japan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02712-1&doi=10.1016/j.jval.2021.11.917
First page :
Section Title :
Open access? :
No
Section Order :
10446